Silver surged 5% on Wednesday to retest the critical $54 resistance, but weakening volume casts doubt on breakout strength, with $50 remaining key support.
An improved outlook, a year-over-year decline in earnings per share, contracting margins, and rising medical costs create an engaging narrative for UnitedHealth Group. Should you buy the sell-off?